Alzheimer's Treatment in Cuba🇨🇺

Cuba's neuroscience centers evaluate each patient individually. Programs are most commonly considered for patients with mild-to-moderate cognitive impairment or early-to-moderate Alzheimer's disease, where cognitive rehabilitation and neuroprotective support can provide the greatest benefit. Eligibility is determined only after a full medical review of diagnosis, imaging, and current clinical status.

Cuba's Center for Genetic Engineering and Biotechnology (CIGB) has investigated NeuroEPO — a recombinant erythropoietin with neuroprotective properties — as a potential supportive approach for neurodegenerative conditions including Alzheimer's. Alongside this, Cuba's International Center for Neurological Restoration (CIREN) provides intensive cognitive rehabilitation, neuropsychological therapy, and pharmacological management. No outcome is guaranteed; each patient is individually evaluated.

Our international patient coordinators handle the entire journey: medical program issuance, visa guidance (a Tourist Card covers stays under 30 days; a medical visa is arranged for longer programs), flights to José Martí International Airport in Havana, airport reception, and accommodation. English, French, and German-speaking coordinators support patients from the US, Canada, and Europe throughout their stay.

Payments are made via international bank transfer or our secure online gateway in Euros, British Pounds, or Canadian Dollars. Patients from the United States should note that transfers cannot be made in US Dollars or from US-capital banks; our team will advise on the most suitable payment route for your situation. Cash is not accepted.

Yes — and we encourage it. We arrange comfortable accommodation for accompanying family members, including adjoining rooms and family suites. Caregiver education is a core part of the program, so families return home confident in supporting the patient's continued care.

Every patient receives a comprehensive medical report detailing the program, progress, and follow-up recommendations. Our telemedicine follow-up program allows continued consultation with your Cuban medical team, and our coordinators remain available to support the family after return to the United States, Canada, or Europe.

Cuba offers a comprehensive, multidisciplinary approach combining neuroprotective biotechnology (NeuralCIM® / NeuroEPO), intensive cognitive rehabilitation, neuropsychological therapy, and personalized pharmacological management. Each program is tailored to the patient's diagnosis and stage, with eligibility determined through a full medical review — offering families an alternative when standard symptom-management care at home is limited.

Yes. Cuba's International Center for Neurological Restoration (CIREN) provides structured memory care for dementia — daily therapy across neurology, neuropsychology, occupational therapy, and speech & language therapy — designed to preserve independence and slow functional decline. The model is family-inclusive, with caregiver education built into every program and telemedicine follow-up after return home.

Caregiver education is a core pillar of Cuba's programs. Families receive structured training in cognitive stimulation techniques, medication management, behavioral strategies, and daily-care routines. After returning home, families continue to receive support through scheduled telemedicine consultations with the Cuban medical team and access to multilingual international coordinators fluent in English, French, Arabic, and Turkish.

Common early Alzheimer's symptoms include short-term memory loss that disrupts daily life, difficulty solving problems or planning, confusion with time or place, withdrawal from work or social activities, and changes in mood or personality. Mild Cognitive Impairment (MCI) often precedes Alzheimer's and is itself a reason to seek evaluation. Cuba's centers evaluate MCI and early-stage Alzheimer's, where neuroprotective and rehabilitative support may offer the greatest benefit.

While no therapy can halt Alzheimer's entirely, Cuba's integrated approach aims to slow cognitive decline through neuroprotective medication to support neuronal survival, intensive cognitive rehabilitation to strengthen preserved function, pharmacological management of associated symptoms, and structured caregiver-led cognitive stimulation at home. Early evaluation and intervention — ideally at the MCI or mild stage — offers the best window for meaningful support.